BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7263839)

  • 1. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.
    Pak CY; Nicar MJ; Peterson R; Zerwekh JE; Snyder W
    J Clin Endocrinol Metab; 1981 Sep; 53(3):536-42. PubMed ID: 7263839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrolithiasis and bone involvement in primary hyperparathyroidism.
    Silverberg SJ; Shane E; Jacobs TP; Siris ES; Gartenberg F; Seldin D; Clemens TL; Bilezikian JP
    Am J Med; 1990 Sep; 89(3):327-34. PubMed ID: 2393037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and evaluation of asymptomatic primary hyperparathyroidism.
    Bilezikian JP; Silverberg SJ; Shane E; Parisien M; Dempster DW
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S85-9; discussion S121-4. PubMed ID: 1662460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?
    D'Angelo A; Lodetti MG; Giannini S; Castrignano R; al Awady M; Malvasi L; Fabris A; Maschio G
    Miner Electrolyte Metab; 1992; 18(6):359-64. PubMed ID: 1291857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gender in primary hyperparathyroidism: same disease, different presentation.
    Mazeh H; Sippel RS; Chen H
    Ann Surg Oncol; 2012 Sep; 19(9):2958-62. PubMed ID: 22535262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism.
    Thakker RV; Fraher LJ; Adami S; Karmali R; O'Riordan JL
    Bone Miner; 1986 Apr; 1(2):137-44. PubMed ID: 3508721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrolithiasis and hyperparathyroidism.
    Broadus AE
    Hosp Pract (Off Ed); 1982 Jan; 17(1):98A, 98G-98H, 98L passim. PubMed ID: 6818128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones.
    Perez AA; Schneider DF; Long KL; Pitt SC; Sippel RS
    J Surg Res; 2018 Dec; 232():564-569. PubMed ID: 30463775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
    J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of primary hyperparathyroidism with and without kidney stones.
    Odvina CV; Sakhaee K; Heller HJ; Peterson RD; Poindexter JR; Padalino PK; Pak CY
    Urol Res; 2007 Jun; 35(3):123-8. PubMed ID: 17476495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary hyperparathyroidism and nephrolithiasis].
    Tiktinskiĭ OL
    Sov Med; 1978 Oct; (10):99-104. PubMed ID: 362554
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.
    Sommer-Tsilenis E
    Eur Urol; 1977; 3(4):231-6. PubMed ID: 913450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria.
    Johansson H; Thorén L; Werner I; Grimelius L
    Surgery; 1975 May; 77(5):691-6. PubMed ID: 1124510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. II. Primary hyperparathyroidism].
    Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
    Pol Arch Med Wewn; 1992 Jan; 87(1):49-53. PubMed ID: 1641364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of blood tests in screening for metabolic disorders in kidney stone disease.
    Eyre KS; Lewis F; Cui H; Grout E; Mihai R; Turney BW; Howles SA
    BJU Int; 2021 May; 127(5):538-543. PubMed ID: 32967050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hypophosphatemia in calcium nephrolithiasis.
    Yamakawa K; Kawamura J
    Mol Urol; 2000; 4(4):365-70. PubMed ID: 11156704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary parameters as predictors of primary hyperparathyroidism in patients with nephrolithiasis.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    J Urol; 2012 Feb; 187(2):516-21. PubMed ID: 22177167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic primary hyperparathyroidism.
    Mitlak BH; Daly M; Potts JT; Schoenfeld D; Neer RM
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S103-10; discussion S121-4. PubMed ID: 1763660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.